![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/kechow-pharma-announces-nmpa-approval-of-tunlametinib-hl-085-as-the-first-targeted-therapy-for-patients-with-nras-mutated-advanced-melanoma-and-previously-treated-with-pd-1pd-l1-302091342.html